Cargando…

The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells

Adipocytes in the breast tumour microenvironment promotes acquired treatment resistance. We used an in vitro adipocyte-conditioned media approach to investigate the direct paracrine effects of adipocyte secretory factors on MDA-MB-231 breast cancer cells treated with doxorubicin to clarify the under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mentoor, Ilze, Engelbrecht, Anna-Mart, van de Vyver, Mari, van Jaarsveld, Paul J., Nell, Theo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632082/ https://www.ncbi.nlm.nih.gov/pubmed/34812105 http://dx.doi.org/10.1080/21623945.2021.1979758

Ejemplares similares

Chemoresistance: Intricate Interplay Between Breast Tumor Cells and Adipocytes in the Tumor Microenvironment
por: Mentoor, Ilze, et al.
Publicado: (2018)

Decreased Efficacy of Doxorubicin Corresponds With Modifications in Lipid Metabolism Markers and Fatty Acid Profiles in Breast Tumors From Obese vs. Lean Mice
por: Mentoor, Ilze, et al.
Publicado: (2020)

Metabolic syndrome and body shape predict differences in health parameters in farm working women
por: Mentoor, Ilze, et al.
Publicado: (2018)

Amino Acid Starvation Sensitizes Resistant Breast Cancer to Doxorubicin-Induced Cell Death
por: Thomas, Mark, et al.
Publicado: (2020)

Domesticating Cancer: An Evolutionary Strategy in the War on Cancer
por: van Niekerk, Gustav, et al.
Publicado: (2017)

Sickness-Associated Anorexia: Mother Nature's Idea of Immunonutrition?
por: van Niekerk, Gustav, et al.
Publicado: (2016)

Circadian Rhythms and Breast Cancer: The Role of Per2 in Doxorubicin-Induced Cell Death
por: Mitchell, Megan I., et al.
Publicado: (2015)

In vitro analyses of paracrine effects of murine classically activated macrophage on beige adipocyte metabolism
por: Yao, Jingfei, et al.
Publicado: (2022)

Obese mammary tumour-bearing mice are highly sensitive to doxorubicin-induced hepatotoxicity
por: Sedeman, Megan, et al.
Publicado: (2022)

Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
por: Christowitz, Claudia, et al.
Publicado: (2019)

EGCG Inhibits Adipose-Derived Mesenchymal Stem Cells Differentiation into Adipocytes and Prevents a STAT3-Mediated Paracrine Oncogenic Control of Triple-Negative Breast Cancer Cell Invasive Phenotype
por: Gonzalez Suarez, Narjara, et al.
Publicado: (2021)

Beneficial paracrine effects of adipocytes from obese rats on cultured endothelial cells
por: Jenkins, Nathan T., et al.
Publicado: (2014)

A paracrine role for white thermogenic adipocytes in innervation: an evidence-based hypothesis
por: Lee, Aejin, et al.
Publicado: (2019)

Peritumoral adipose tissue promotes lipolysis and white adipocytes browning by paracrine action
por: Pagnotta, Priscila, et al.
Publicado: (2023)

Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer
por: Chougule, Mahavir B., et al.
Publicado: (2011)

Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer
por: Bawaneh, Alaa, et al.
Publicado: (2022)

Adipocyte-Derived Paracrine Factors Regulate the In Vitro Development of Bovine Mammary Epithelial Cells
por: Dzięgelewska-Sokołowska, Żaneta, et al.
Publicado: (2023)

Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
por: Xie, Yizhao, et al.
Publicado: (2022)

Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells
por: Fathy Abd-Ellatef, Gamal-Eldein, et al.
Publicado: (2020)

Mesenchymal Stem Cell-Induced Doxorubicin Resistance in Triple Negative Breast Cancer
por: Chen, Dar-Ren, et al.
Publicado: (2014)

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
por: Berry, Jameson T.L., et al.
Publicado: (2020)

IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
por: Hum, Nicholas R., et al.
Publicado: (2022)

Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism
por: Sartorius, Carol A., et al.
Publicado: (2015)

Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis
por: Su, Jung-Chen, et al.
Publicado: (2016)

Comparative Evaluation of the Cytotoxicity of Doxorubicin in BT-20 Triple-Negative Breast Carcinoma Monolayer and Spheroid Cultures
por: Ncube, Keith N., et al.
Publicado: (2023)

ER Stress and Lipid Metabolism in Adipocytes
por: Zha, Beth S., et al.
Publicado: (2012)

Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin
por: Krausz, Aimee E., et al.
Publicado: (2018)

Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin
por: Inao, Touko, et al.
Publicado: (2018)

Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo
por: Lothstein, Leonard, et al.
Publicado: (2020)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
por: Martin, Miguel, et al.
Publicado: (2021)

Folate-Functionalized DNA Origami for Targeted Delivery of Doxorubicin to Triple-Negative Breast Cancer
por: Pal, Suchetan, et al.
Publicado: (2021)

High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
por: Torres-Ruiz, Sandra, et al.
Publicado: (2023)

ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy
por: Zhou, Jingyi, et al.
Publicado: (2023)

Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer
por: Zeng, Weiwei, et al.
Publicado: (2023)

MicroRNA therapy confers anti-senescent effects on doxorubicin-related cardiotoxicity by intracellular and paracrine signaling
por: Xia, Wenzheng, et al.
Publicado: (2021)

A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast Cancer
por: McKenna, Matthew T., et al.
Publicado: (2017)

Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin
por: Salerno, Dominick, et al.
Publicado: (2021)

Cytoprotective Effect of Vitamin D on Doxorubicin-Induced Cardiac Toxicity in Triple Negative Breast Cancer
por: Lee, Kevin J, et al.
Publicado: (2021)

Pharmacometabolomics reveals urinary diacetylspermine as a biomarker of doxorubicin effectiveness in triple negative breast cancer
por: Velenosi, Thomas J., et al.
Publicado: (2022)

Metabolomics Analysis Reveals Altered Metabolic Pathways and Response to Doxorubicin in Drug-Resistant Triple-Negative Breast Cancer Cells
por: Rushing, Blake R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o4jm0jvc9sltu4ue0jauac2run